Noemí Reguart
Oncology Department OncologistResearch group
- Translational genomics and targeted therapies in solid tumours Accredited researcher (R3A)
Featured publications
-
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer
Authors:Reference: New England Journal Of Medicine 2020.
Featured Projects
-
PEERs: A phase II trial of Lenvatinib, pembrolizumab and carboplatin-etoposide in extended-small cell lung cancer. Includes translational exploratory research to identify biomarkers in tissue samples.
Principal investigator: Noemi Reguart AransayFunder: MSD ; GECP (Promotor)Code: 2020-005230-15Duration: 01/10/2020 - 01/10/2026 -
Validación de un Ensayo Multiplex Personalizado para la detección de Oncogenes y Firmas Inmunes en Cáncer de Pulmón (CP): Estudio Observacional, Prospectivo y Multicéntrico
Principal investigator: Noemi Reguart AransayFunder: Instituto de Salud Carlos III (Sede o evento)Code: PI16/00890Duration: 01/01/2017 - 01/01/2019